278 results on '"Glotzbecker, Brett"'
Search Results
2. Resident-Reported Impact of a Novel Oncology Curriculum for Internal Medicine Residents
3. Integrative omics to detect bacteremia in patients with febrile neutropenia.
4. Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease
5. Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation
6. Information Needs for Treatment Decision-making of Hematopoietic Cell Transplant Patients 65 Years or Older and Caregivers
7. A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis
8. Lack of impact of umbilical cord blood unit processing techniques on clinical outcomes in adult double cord blood transplant recipients
9. Readmissions after Umbilical Cord Blood Transplantation and Impact on Overall Survival
10. Ciprofloxacin-Associated Hypoglycemia
11. Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease
12. Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years
13. Hematopoietic Cell Transplantation in Patients with Medication-Related Osteonecrosis of the Jaws
14. Defibrotide formulations contain (1→3)-β-D-glucan that could influence clinical diagnostic testing
15. A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial
16. Risk Factors for Readmission after Allogeneic Hematopoietic Stem Cell Transplantation and Impact on Overall Survival
17. Outcomes of Immune Checkpoint Inhibitor Administration in Hospitalized Patients With Solid Tumor Malignancies
18. The utility of procalcitonin for diagnosing bacteremia and bacterial pneumonia in hospitalized oncology patients
19. Donor Chimerism Early after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation Predicts Relapse and Survival
20. Risk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myeloma
21. Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation
22. Outcomes in Patients Age 70 or Older Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
23. Phase I Study of Alemtuzumab for Therapy of Steroid-Refractory Chronic Graft-versus-Host Disease
24. Outcomes of Immune Checkpoint Inhibitor Administration in Hospitalized Patients With Solid Tumor Malignancies.
25. Important Drug Interactions in Hematopoietic Stem Cell Transplantation: What Every Physician Should Know
26. Next-Generation Sequencing to Assess the Impact of Low Dose Melphalan on Residual Disease before High-Dose Melphalan and Stem Cell Transplant in Multiple Myeloma
27. Epigenetic Priming with Pre-Transplant Oral Panobinostat Followed By Post-Transplant Consolidation
28. Biosimilar strategic implementation at a large health system
29. Resident-Reported Impact of a Novel Oncology Curriculum for Internal Medicine Residents
30. Lenalidomide enhances anti-myeloma cellular immunity
31. Hematology and Oncology
32. CLO21-016: Incidence, Risk Factors, and Prognostic Implications of Peri-Transplant Orthostatic Hypotension in Patients With Multiple Myeloma
33. Efficacy and cost-benefit of filgrastim administered after early assessment bone marrow biopsy during induction therapy for acute myeloid leukemia
34. Randomized Study of enterade® to Reduce Diarrhea in Patients Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation
35. Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease
36. Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease
37. Improvements in Sepsis-associated Mortality in Hospitalized Patients with Cancer versus Those without Cancer. A 12-Year Analysis Using Clinical Data
38. Turning over the Beds – How Optimizing Pre-Discharge Patient Teaching Reduced Discharge Delays in the Inpatient Hospital at Dana-Farber Cancer Institute and Brigham and Women's Hospital
39. Outcomes of immunotherapy administration for hospitalized cancer patients.
40. Outcomes of immunotherapy administration for hospitalized cancer patients.
41. A phase II, double-blinded, randomized study using a proprietary amino acid mixture as diarrhea prevention in patients undergoing autologous stem cell transplantation (AST) for multiple myeloma (MM) and non-Hodgkin lymphoma (NHL).
42. Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation
43. Information Needs for Treatment Decision-making of Hematopoietic Cell Transplant Patients 65 Years or Older and Caregivers
44. Genetic Predispositions, Management Strategies, and Clinical Outcomes in Adults with Hemophagocytic Lymphohistiocytosis (HLH) after Reduced-Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation (HSCT) at Dana-Farber Cancer Institute
45. Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation
46. Incidence and Predictors of Hepatic Veno-Occlusive Disease after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation
47. 1576. Risk of Clinical Tuberculosis (TB) Among Patients with Latent TB Infection (LTBI) Who Undergo Allogeneic Hematopoietic-Cell Transplantation (HCT)
48. A Proprietary Amino-Acid-Mixture As Diarrhea Prevention In Patients Undergoing Autologous Stem-Cell-Transplantation (ASCT) For Multiple-Myeloma (MM) And Non-Hodgkin-Lymphoma (NHL)
49. A data driven approach to immunotherapy toxicity management.
50. Evaluating the adverse effects of melphalan formulations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.